Acrivon Therapeutics, Inc. (ACRV)
(Delayed Data from NSDQ)
$7.23 USD
+0.21 (2.99%)
Updated Aug 15, 2024 04:00 PM ET
After-Market: $7.28 +0.05 (0.69%) 6:28 PM ET
2-Buy of 5 2
D Value C Growth B Momentum D VGM
Earnings News For ACRV
-
Acrivon Therapeutics Reports Second Quarter 2024 Financial Results and Business Highlights
-
Acrivon Therapeutics Reports First Quarter 2024 Financial Results and Business Highlights
-
Acrivon Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights
-
Acrivon Therapeutics Reports Third Quarter 2023 Financial Results and Business Highlights
-
Acrivon Therapeutics Reports Second Quarter 2023 Financial Results and Business Highlights
-
Acrivon Therapeutics Reports First Quarter 2023 Financial Results and Business Highlights
-
Acrivon Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Business Highlights